DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award
Can you apply?
This grant is for lung cancer research focused on patient-centered outcomes and survivorship. Eligible applicants typically include academic medical centers, research institutions, and nonprofit organizations with cancer research capacity. Applicants must have institutional infrastructure to conduct clinical or translational research on lung cancer survivors. Geographic scope is U.S.-based institutions. Activities supported include research on survivorship outcomes, quality of life, long-term health effects, and patient-centered care models for lung cancer survivors.
Projects should align with Department of Defense priorities for cancer research. Strong institutional commitment and relevant expertise in oncology or patient outcomes research is expected. Collaboration between research and patient advocacy groups is encouraged.
Program description
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category.
Distinctive Features:
• This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver.
• This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.
Who can apply
Eligible applicants
Demographic focus
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (Federal Application Form)
- Project Narrative (typically 15 pages)
- Budget and Budget Justification
- Biographical Sketches (PI and key personnel)
- Institutional Support Letter
- Letters of Collaboration (if applicable)
- Institutional IRB and IACUC Approvals (if applicable)
Program contact
- 👤 Danielle Reckley Grantor
- 📧 help@eBRAP.org
- 📞 301-619-1139
Funding track record
Recent awards under CFDA 12.420 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$2,265,729,366
-
$800,631,761
-
$74,531,880
-
$67,205,571
-
$53,718,832
-
$34,191,124
-
$24,907,742
-
$21,394,379
-
$19,100,256
-
$19,002,641
Top States by Funding
- MD 10 awards $3,150.1M
- NC 11 awards $132.3M
- FL 8 awards $99.8M
- CA 11 awards $99.3M
- MA 7 awards $75.2M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 12.420). How funding has trended year over year.
| 2024 | $1,483,968,520 | |
| 2025 | $1,201,153,417 |
FAQ
Who can apply for this award?
Academic institutions, research hospitals, and 501(c)(3) nonprofits with lung cancer research programs. Your institution must have institutional review board (IRB) and grants management capacity.
What is the application deadline?
The deadline is September 2, 2026. Applications open May 5, 2026. Plan to submit 4-5 months ahead of the final deadline.
What types of research activities are supported?
Survivorship outcomes research, patient-reported outcomes, quality of life studies, and long-term side effect management for lung cancer survivors.
How competitive is this award?
DoD cancer research grants are moderately to highly competitive. Strong preliminary data and clear patient impact are essential.
What is the typical funding range?
DoD AMRAA awards typically range from $150,000 to $500,000 per year. Review the full solicitation for specific budget caps.
💡 Tips for applicants
- Start with strong preliminary data showing your team's track record in lung cancer or survivorship research.
- Center your proposal on patient needs and input. Include survivor testimonials or patient advisory board feedback.
- Align your outcomes metrics with DoD priorities: readiness, health equity, and reduction of long-term burden.
- Build in partnerships with patient advocacy groups or lung cancer survivor networks for credibility.
- Address health disparities in lung cancer survivors. DoD increasingly funds equity-focused research.
⚠️ Common mistakes
Proposals lack patient voices or real survivorship data. Many fail to connect outcomes research to military or veteran populations explicitly. Budgets exceed allowable amounts or lack clear justification for personnel costs.
Similar grants
- OPEN Strengthening U.S. Market Mastery and Investment Ties (SUMMIT) — U.S. Mission to Jordan
- OPEN Rural Community Health Integration2026 — New York State Department of Health
- OPEN FY26 Bureau of Land Management Rangeland Resource Management – Bureau wide — Bureau of Land Management
- OPEN FY26 Bureau of Land Management Cultural and Paleontological Resource Management – Bureau wide — Bureau of Land Management
- OPEN FY26 Bureau of Land Management Youth Conservation Corps – Bureau wide — Bureau of Land Management